Intravascular hematocrit layering in equilibrium phase contrast-enhanced MR angiography of the peripheral vasculature

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 6, 2006, Pages 1393-1400

  Wang, Maisie S ^a   Haynor, David R ^a,b   Wilson, Gregory J ^c   Maki, Jeffrey H ^b,d  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood pool contrast agents; Deep vein thrombosis; Equilibrium phase; Hematocrit; Magnetic resonance angiography; Slow flowing veins

Indexed keywords

CONTRAST MEDIUM;

ADULT; ARTICLE; BLOOD; BLOOD FLOW; BLOOD FLOWMETRY; BLOOD VESSEL DIAMETER; BLOOD VESSEL PARAMETERS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; EVALUATION; EX VIVO STUDY; HEMATOCRIT; HEMATOCRIT LAYERING; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR SYSTEM; PHLEBOGRAPHY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM; HEMATOCRIT; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; VEINS;

EID: 33845335512     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20773     Document Type: Article

References (12)

1. Perreault P, Edelman MA, Baum RA, et al. MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 2003;229:811-820.
2. Parmelee DJ, Walovitch RC, Ouellet HS, Randall B, Lauffer B. Preclinical evaluations of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32:741-747.
3. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography, Radiology 1998;207:529-538.
4. Hoffman U, Loewe C, Bernhard C, et al. MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience. J Magn Reson Imaging 2002;15:429-437.
5. Aschauer M, Deutschmann HA, Stollberger R, et al. Value of a blood pool contrast agent in MR venography of the lower extremities and pelvis: preliminary results in 12 patients. Magn Reson Med 2003;50:993-1002.
6. Lin MC, Forrest JV, Mattrey RF, Lasser EC. Intravascular hematocrit effect in cross-sectional CT imaging. J Comput Assist Tomogr 1991;15:464-466.
7. Garg K, Kemp JL, Wojcik D. Thromboembolic disease: comparison of combined CT pulmonary angiography and venography with bilateral leg sonography in 70 patients. AJR Am J Roentgenol 2000;175:997-1001.
8. Garg K, Mao J. Deep venous thrombosis: spectrum of findings and pitfalls in interpretation on CT venography. AJR Am J Roentgenol 2001;177:319-323.
9. Ghaye B, Szapiro D, Willems V, Dondelinger RF. Pitfalls in CT venography of lower limbs and abdominal veins. AJR Am J Roentgenol 2002;178:1465-1471.
10. Ghaye B, Dondelinger RF. Non-traumatic thoracic emergencies: CT venography in an integrated diagnostic strategy of acute pulmonary embolism and venous thrombosis. Eur Radiol 2002;12:1906-1921.
11. Lau C, Pathak SD, Gong L, Kinahan P, Cheng P, Ng L. Advanced PET/CT fusion workstation for oncology imaging. Proc SPIE Med Imaging 2005;5744:670-676.
12. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250.